Search

everythinglearnresearchcommunity

for

Search:↓

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Using platelet-rich plasma and fat grafting to treat nerve pain showed promising results with no side effects.

Modifying certain signals in the body can help wounds heal without scars and regrow hair.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Hirsutism causes significant psychological distress in women.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Different types of PCOS need specific diagnosis methods and treatments.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

The enzymes Tet1, Tet2, and Tet3 are important for the development of hair follicles and determining hair shape by controlling hair keratin genes.

The skin protects the body and is constantly renewed by stem cells; disruptions can lead to cancer.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Eclipta prostrata has many traditional uses and health benefits, but more research is needed to understand how it works and ensure it's safe.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Tadalafil and Finasteride may help treat aggressive melanoma.

The human scalp hair bulb contains different types of melanocytes with varying abilities to produce melanin.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.